Transgenic models for haemopoietic malignancies - PubMed (original) (raw)

Review

Transgenic models for haemopoietic malignancies

J M Adams et al. Biochim Biophys Acta. 1991.

No abstract available

PubMed Disclaimer

Similar articles

• Marek's disease and its implication for the prevention of lymphoma and leukemia.
  Pomeroy BS, Paul P. Pomeroy BS, et al. Medicine (Baltimore). 1973 Jul;52(4):363-5. doi: 10.1097/00005792-197307000-00015. Medicine (Baltimore). 1973. PMID: 4722660 No abstract available.
• [Transgenic animals and their means of application].
  Cartier N. Cartier N. Diabete Metab. 1993 Jan-Feb;19(1):61-7. Diabete Metab. 1993. PMID: 8504887 French. No abstract available.
• [Target cells and tissue microenvironment in the development of thymic lymphomas in mice: a model for the study of the role of host factors in carcinogenesis].
  Boniver J, Defresne MP. Boniver J, et al. Bull Mem Acad R Med Belg. 1988;143(1-2):114-22. Bull Mem Acad R Med Belg. 1988. PMID: 3179587 French. No abstract available.
• Zebrafish models of leukemia.
  He S, Jing CB, Look AT. He S, et al. Methods Cell Biol. 2017;138:563-592. doi: 10.1016/bs.mcb.2016.11.013. Epub 2017 Jan 7. Methods Cell Biol. 2017. PMID: 28129858 Review.
• Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector.
  Adams JM, Harris AW, Strasser A, Ogilvy S, Cory S. Adams JM, et al. Oncogene. 1999 Sep 20;18(38):5268-77. doi: 10.1038/sj.onc.1202997. Oncogene. 1999. PMID: 10498879 Review.

Cited by

• Assessing the potential carcinogenic activity of magnetic fields using animal models.
  McCann J, Kavet R, Rafferty CN. McCann J, et al. Environ Health Perspect. 2000 Mar;108 Suppl 1(Suppl 1):79-100. doi: 10.1289/ehp.00108s179. Environ Health Perspect. 2000. PMID: 10698725 Free PMC article. Review.
• INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.
  Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW. Schmitt CA, et al. Genes Dev. 1999 Oct 15;13(20):2670-7. doi: 10.1101/gad.13.20.2670. Genes Dev. 1999. PMID: 10541553 Free PMC article.
• No requirement for V(D)J recombination in p53-deficient thymic lymphoma.
  Liao MJ, Zhang XX, Hill R, Gao J, Qumsiyeh MB, Nichols W, Van Dyke T. Liao MJ, et al. Mol Cell Biol. 1998 Jun;18(6):3495-501. doi: 10.1128/MCB.18.6.3495. Mol Cell Biol. 1998. PMID: 9584189 Free PMC article.
• Recent advances in transgenic technology.
  Cameron ER. Cameron ER. Mol Biotechnol. 1997 Jun;7(3):253-65. doi: 10.1007/BF02740816. Mol Biotechnol. 1997. PMID: 9219239 Review.
• Testing electromagnetic fields for potential carcinogenic activity: a critical review of animal models.
  McCann J, Kavet R, Rafferty CN. McCann J, et al. Environ Health Perspect. 1997 Feb;105 Suppl 1(Suppl 1):81-103. doi: 10.1289/ehp.97105s181. Environ Health Perspect. 1997. PMID: 9114279 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information